Miles Congreve

E474944

Miles Congreve is a pharmaceutical scientist and entrepreneur best known as a co-founder of Heptares Therapeutics, a company specializing in structure-based drug discovery targeting G protein–coupled receptors (GPCRs).

All labels observed (1)

Label Occurrences
Miles Congreve canonical 1

How this entity was disambiguated

Statements (26)

Predicate Object
instanceOf company founder
entrepreneur
pharmaceutical scientist
associatedWith Sosei Heptares NERFINISHED
coFounded Heptares Therapeutics NERFINISHED
countryOfActivity United Kingdom NERFINISHED
employer Heptares Therapeutics NERFINISHED
fieldOfWork G protein–coupled receptor biology
drug discovery
medicinal chemistry
pharmaceutical sciences
hasRole drug discovery project leader
scientific leader at Heptares Therapeutics
industry biotechnology
pharmaceutical industry
knownFor co-founding Heptares Therapeutics
research on G protein–coupled receptors
structure-based drug discovery
notableContribution application of structure-based methods to GPCR drug discovery
development of GPCR-targeted therapeutics at Heptares Therapeutics
specializesIn G protein–coupled receptors NERFINISHED
biologics design
small-molecule therapeutics
structure-based drug design
workFocus structure-based design of biologics
structure-based design of small-molecule drugs

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Heptares Therapeutics foundedBy Miles Congreve